It shows that the use of PCT together with Mid-regional Pro-atrial Natriuretic Peptide (MR-proANP) supports the differential diagnosis of pneumonia and congestive heart failure [85]. The gene discussed is NPPA; the disease is susceptibility to pneumonia measurement.